• BKT140 (BL-8040): CXCR4 Antagonist for Tumor Microenvironmen

  2026-06-09

  Explore how BKT140 (BL-8040) antagonizes CXCR4 to disrupt the tumor microenvironment, inhibit cancer progression, and mobilize hematopoietic stem cells. This in-depth review offers unique insights into assay design and clinical translation, distinguishing itself from prior reviews.

• ω-Agatoxin IVA TFA: Precision P/Q-Type Channel Block in Rese

  2026-06-09

  ω-Agatoxin IVA TFA empowers researchers to dissect P/Q-type Cav2.1 channel function with nanomolar precision, facilitating advanced neuronal calcium current recording and synaptic transmission research. Its reproducibility and specificity, validated in both in vitro and in vivo models, give neurophysiology labs a decisive edge in epilepsy and neuroprotection studies.

• DMG-PEG2000-NH2: Reliable Linker for Liposomal Drug Delivery

  2026-06-08

  This article addresses common laboratory hurdles in cell-based assays and drug delivery research, illustrating how DMG-PEG2000-NH2 (SKU M2006) streamlines amide bond formation and improves workflow reproducibility. Scenario-driven guidance demonstrates how this NH2-PEG derivative from APExBIO delivers consistent results for lipid nanoparticle and liposomal platforms.

• Flavopiridol (L868275): Protocols and Pitfalls in Cancer Res

  2026-06-08

  Flavopiridol (L868275) empowers cancer research with robust, reproducible cell cycle arrest and apoptosis workflows via pan-CDK inhibition. This guide translates cutting-edge findings from ER stress studies into actionable protocols and troubleshooting strategies, ensuring high-impact results with APExBIO quality.

• Antibacterial Drug Use and Resistance Patterns in Psychiatri

  2026-06-07

  This study provides a systematic analysis of antibacterial drug use and bacterial resistance in a psychiatric hospital during the COVID-19 epidemic, revealing a nuanced relationship between responsible antimicrobial stewardship and emerging resistance patterns. The findings highlight both strengths and persistent challenges in optimizing antibiotic protocols within psychiatric care settings.

• Metformin Hydrochloride: Protocols and Pitfalls in Metabolic

  2026-06-06

  Metformin Hydrochloride (Metformin HCl) is a gold-standard AMPK signaling pathway modulator, enabling precise interrogation of glucose metabolism, immune modulation, and ectopic ossification. This article delivers actionable protocols, troubleshooting guidance, and comparative insights for harnessing Metformin HCl in advanced metabolic and immunometabolic studies.

• Berberine Suppresses SASP in Atherosclerosis via RXRα/PPARγ/

  2026-06-05

  The reference study uncovers how berberine inhibits senescence-associated secretory phenotype (SASP)-driven inflammation in atherosclerosis by activating the RXRα/PPARγ/NEDD4 signaling axis. These mechanistic insights highlight new opportunities to dissect macrophage-driven vascular aging and inform targeted experimental approaches for modulating PPARγ signaling in disease models.

• Practical Use of HyperScribe™ T7 High Yield Cy3 RNA Labeling

  2026-06-05

  The HyperScribe™ T7 High Yield Cy3 RNA Labeling Kit Plus enables researchers to efficiently synthesize Cy3-labeled RNA probes for applications such as in situ hybridization and Northern blotting. It is intended exclusively for research workflows requiring fluorescent RNA detection and should not be used for diagnostic or clinical purposes.

• In Vitro Antibacterial Spectrum of Leucomycin: Insights and

  2026-06-04

  The 1962 reference study systematically characterized leucomycin’s in vitro antibacterial activity, focusing on its efficacy against a broad panel of Gram-positive and selected Gram-negative bacteria, including antibiotic-resistant staphylococci. These foundational insights inform current research on acetoxy-substituted macrolide antibiotics, such as midecamycin, and guide the development of experimental protocols for studying bacterial protein synthesis inhibition and resistance.

• Caspase-3 Colorimetric Assay Kit: Technical Use and Protocol

  2026-06-04

  The Caspase-3 Colorimetric Assay Kit enables sensitive, quantitative detection of DEVD-dependent caspase-3 activity, providing a reliable tool for apoptosis and caspase signaling pathway research. It is not suitable for in vivo imaging or for measuring non-caspase-3 proteases. Researchers should follow recommended protocols to ensure robust results and avoid common pitfalls.

• SU6656 Src Tyrosine Kinases Inhibitor: Reliable Protocols &

  2026-06-03

  This article addresses real-world challenges in cell-based assays and megakaryocyte differentiation, illustrating how SU6656 Src tyrosine kinases inhibitor (SKU B5839) delivers reproducible, data-backed solutions. Bench researchers will find scenario-driven Q&A, practical protocol tips, and evidence-based advice for optimizing workflows.

• Brefeldin A: Optimizing ER Stress and Apoptosis Assays in Ca

  2026-06-03

  Brefeldin A (BFA) is a gold-standard ER stress inducer and vesicular transport inhibitor, essential for dissecting protein trafficking, apoptosis, and endothelial dysfunction in translational cancer and vascular biology. This guide covers advanced workflows, troubleshooting, and practical insights, drawing on recent biomarker discoveries and mechanistic research to elevate your experimental success with APExBIO’s Brefeldin A.

• IgSF6 Deficiency Enhances ER Stress and Antibacterial Activi

  2026-06-02

  This study uncovers how deficiency of the ER-localized immunoglobulin IgSF6 in intestinal macrophages amplifies antibacterial activity through increased ER stress and inflammatory signaling. The findings provide mechanistic insight into the regulation of gut immune homeostasis and highlight new avenues for studying macrophage-driven defense and inflammation.

• Biotin-XX Tyramide Reagent: Membrane-Impermeant Signal Ampli

  2026-06-02

  Biotin-XX Tyramide Reagent enables high-sensitivity, membrane-impermeant cell surface protein labeling through tyramide signal amplification. Its long polar linker restricts biotinylation to extracellular targets, improving specificity for immunohistochemistry and in situ hybridization. This reagent, supplied by APExBIO, is benchmarked in neuroscience applications and offers robust, selective profiling for low-abundance proteins.

• Spatially Concentrated ABEs Correct PLP1 Mutations in Oligod

  2026-06-01

  This study introduces a spatially concentrated adenine base editor (cABE) strategy to efficiently correct pathogenic PLP1 mutations in oligodendrocytes, addressing a major challenge in gene therapy for myelin disorders. The approach enhances nuclear localization of the editing machinery, improving on-target efficiency while minimizing transcriptome-wide off-target effects.

16730 records 1/1116 page Next 12345 下5页 Last page